These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36704632)

  • 1. The age of onset and cognitive impairment at the early stage of schizophrenia.
    Yin Y; Li S; Tong J; Huang J; Tian B; Chen S; Cui Y; Tan S; Wang Z; Yang F; Tong Y; Hong LE; Tan Y
    Cogn Neurodyn; 2023 Feb; 17(1):183-190. PubMed ID: 36704632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia.
    Yin Y; Li S; Tong J; Huang J; Tian B; Chen S; Cui Y; Tan S; Wang Z; Yang F; Tong Y; Hong LE; Tan Y
    Schizophr Res; 2023 Jul; 257():58-63. PubMed ID: 37290277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do clinical characteristics predict the cognitive course in early-onset schizophrenia-spectrum disorders?
    Teigset CM; Mohn C; Brunborg C; Juuhl-Langseth M; Holmén A; Rund BR
    J Child Psychol Psychiatry; 2018 Sep; 59(9):1012-1023. PubMed ID: 29573345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is late-onset schizophrenia a subtype of schizophrenia?
    Vahia IV; Palmer BW; Depp C; Fellows I; Golshan S; Kraemer HC; Jeste DV
    Acta Psychiatr Scand; 2010 Nov; 122(5):414-26. PubMed ID: 20199491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia.
    Zhao N; Wang XH; Kang CY; Zheng Y; Yang LY; Guan TF; Bai YX; Wei R; Hinman HC; Zhang XY
    Ann Gen Psychiatry; 2021 Apr; 20(1):26. PubMed ID: 33882965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are negative symptoms really related to cognition in schizophrenia?
    Bagney A; Dompablo M; Santabárbara J; Moreno-Ortega M; Lobo A; Jimenez-Arriero MA; Palomo T; Rodriguez-Jimenez R
    Psychiatry Res; 2015 Dec; 230(2):377-82. PubMed ID: 26454405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in cognitive improvements after two months of atypical antipsychotic treatment in first episode schizophrenia.
    Li W; Cao X; Liang Q; Li Y; Zhou C; Du J; Xie S
    Front Psychiatry; 2024; 15():1369532. PubMed ID: 38742135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis.
    Mørch-Johnsen L; Smelror RE; Andreou D; Barth C; Johannessen C; Wedervang-Resell K; Wortinger LA; Díaz R; Victoria G; Ueland T; Andreassen OA; Myhre AM; Rund BR; Ulloa RE; Agartz I
    Front Psychiatry; 2021; 12():825681. PubMed ID: 35069300
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study.
    Zhou Y; Li G; Li D; Cui H; Ning Y
    J Psychopharmacol; 2018 May; 32(5):524-532. PubMed ID: 29493377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.
    Rek-Owodziń K; Tyburski E; Plichta P; Waszczuk K; Bielecki M; Wietrzyński K; Podwalski P; Rudkowski K; Michalczyk A; Grąźlewski T; Sagan L; Kucharska-Mazur J; Samochowiec J; Mak M
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
    McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
    Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.